117 related articles for article (PubMed ID: 2144465)
1. Trisomy 21 in transient myeloproliferative disorder.
Faed MJ; Robertson J; Todd AS; Sivakumaran M; Tarnow-Mordi WO
Cancer Genet Cytogenet; 1990 Sep; 48(2):259-64. PubMed ID: 2144465
[TBL] [Abstract][Full Text] [Related]
2. Transient myeloproliferative disorder in chromosomally normal newborn infant.
Kalousek DK; Chan KW
Med Pediatr Oncol; 1987; 15(1):38-41. PubMed ID: 2951583
[TBL] [Abstract][Full Text] [Related]
3. Lineage-specific trisomy 21 in a neonate with resolving transient myeloproliferative syndrome.
Slayton WB; Spangrude GJ; Chen Z; Greene WF; Virshup D
J Pediatr Hematol Oncol; 2002; 24(3):224-6. PubMed ID: 11990311
[TBL] [Abstract][Full Text] [Related]
4. Risk for leukemia in infants without Down syndrome who have transient myeloproliferative disorder.
Cushing T; Clericuzio CL; Wilson CS; Taub JW; Ge Y; Reichard KK; Winter SS
J Pediatr; 2006 May; 148(5):687-9. PubMed ID: 16737888
[TBL] [Abstract][Full Text] [Related]
5. Disomic homozygosity in 21-trisomic cells: a mechanism responsible for transient myeloproliferative syndrome.
Abe K; Kajii T; Niikawa N
Hum Genet; 1989 Jul; 82(4):313-6. PubMed ID: 2525515
[TBL] [Abstract][Full Text] [Related]
6. Characterization of the blast cell population in two neonates with Down's syndrome and transient myeloproliferative disorder.
Coulombel L; Derycke M; Villeval JL; Leonard C; Breton-Gorius J; Vial M; Bourgeois P; Tchernia G
Br J Haematol; 1987 May; 66(1):69-76. PubMed ID: 2954579
[TBL] [Abstract][Full Text] [Related]
7. Transient myeloproliferative syndrome/transient acute myeloid leukemia in a newborn with Down syndrome: a case report and literature review.
D'Angelo G; Merlo P
Lab Hematol; 2003; 9(1):38-41. PubMed ID: 12661826
[TBL] [Abstract][Full Text] [Related]
8. Leukemia and/or myeloproliferative syndrome in neonates with Down syndrome.
Zipursky A; Brown E; Christensen H; Sutherland R; Doyle J
Semin Perinatol; 1997 Feb; 21(1):97-101. PubMed ID: 9190039
[TBL] [Abstract][Full Text] [Related]
9. Transient leukemia (transient myeloproliferative disorder, transient abnormal myelopoiesis) of Down syndrome.
Brink DS
Adv Anat Pathol; 2006 Sep; 13(5):256-62. PubMed ID: 16998319
[TBL] [Abstract][Full Text] [Related]
10. Cryptic deletions and inversions of chromosome 21 in a phenotypically normal infant with transient abnormal myelopoiesis: a molecular cytogenetic study.
Kempski HM; Craze JL; Chessells JM; Reeves BR
Br J Haematol; 1998 Nov; 103(2):473-9. PubMed ID: 9827922
[TBL] [Abstract][Full Text] [Related]
11. Transient myeloproliferative disorder associated with trisomy 21, a wide range syndrome: report of two cases with trisomy 21 mosaicism.
Zubizarreta P; Muriel FS; Fernández Barbieri MA
Med Pediatr Oncol; 1995 Jul; 25(1):60-4. PubMed ID: 7753004
[TBL] [Abstract][Full Text] [Related]
12. Transient myeloproliferative disorder with trisomy 12.
Basu B; Gupta V
Pediatr Hematol Oncol; 2010 Apr; 27(3):233-6. PubMed ID: 20367267
[TBL] [Abstract][Full Text] [Related]
13. Infants with Down's syndrome. Use of cytogenetic studies and in vitro colony assay for granulocyte progenitor to distinguish acute nonlymphocytic leukemia from a transient myeloproliferative disorder.
de Alarcon PA; Patil S; Golberg J; Allen JB; Shaw S
Cancer; 1987 Sep; 60(5):987-93. PubMed ID: 2955884
[TBL] [Abstract][Full Text] [Related]
14. Fetal hydrops and hepatosplenomegaly in the second half of pregnancy: a sign of myeloproliferative disorder in fetuses with trisomy 21.
Smrcek JM; Baschat AA; Germer U; Gloeckner-Hofmann K; Gembruch U
Ultrasound Obstet Gynecol; 2001 May; 17(5):403-9. PubMed ID: 11380964
[TBL] [Abstract][Full Text] [Related]
15. Transient neonatal myeloproliferative disorder without Down syndrome and detection of GATA1 mutation.
Magalhães IQ; Splendore A; Emerenciano M; Córdoba MS; Córdoba JC; Allemand PA; Ferrari I; Pombo-de-Oliveira MS
J Pediatr Hematol Oncol; 2005 Jan; 27(1):50-2. PubMed ID: 15654280
[TBL] [Abstract][Full Text] [Related]
16. Immunophenotype of a transient myeloproliferative disorder in a newborn with trisomy 21.
Girodon F; Favre B; Couillaud G; Carli PM; Parmeland C; Maynadié M
Cytometry; 2000 Apr; 42(2):118-22. PubMed ID: 10797450
[TBL] [Abstract][Full Text] [Related]
17. Additional chromosome abnormalities in transient abnormal myelopoiesis in Down's syndrome patients.
Kounami S; Aoyagi N; Tsuno H; Suzuki H; Kitano N; Koike M
Acta Haematol; 1997; 98(2):109-12. PubMed ID: 9286308
[TBL] [Abstract][Full Text] [Related]
18. Transient myeloproliferative disorder with partial trisomy 21.
Takahashi T; Inoue A; Yoshimoto J; Kanamitsu K; Taki T; Imada M; Yamada M; Ninomiya S; Toki T; Terui K; Ito E; Shimada A
Pediatr Blood Cancer; 2015 Nov; 62(11):2021-4. PubMed ID: 26138905
[TBL] [Abstract][Full Text] [Related]
19. Transient abnormal myelopoiesis in a phenotypically normal newborn with polyclonal trisomy 21.
Corazza F; Astolfi A; Libri V; Franzoni M; Serravalle S; Alessandroni R; Melchionda F; Pession A
Int J Hematol; 2014 Jun; 99(6):794-7. PubMed ID: 24771229
[TBL] [Abstract][Full Text] [Related]
20. Trisomy of Erg is required for myeloproliferation in a mouse model of Down syndrome.
Ng AP; Hyland CD; Metcalf D; Carmichael CL; Loughran SJ; Di Rago L; Kile BT; Alexander WS
Blood; 2010 May; 115(19):3966-9. PubMed ID: 20007548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
